Immunostimulatory Profile of Cancer Cell Death by the AdV-Lumc007-Derived Oncolytic Virus ‘GoraVir’ in Cultured Pancreatic Cancer Cells
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy which shows unparalleled therapeutic resistance. Oncolytic viruses have emerged as a new treatment approach and convey their antitumor activity through lysis of cancer cells. The therapeutic efficacy of oncolytic viruses is la...
Main Authors: | Selas T. F. Bots, Sanne L. Landman, Martijn J. W. E. Rabelink, Diana J. M. van den Wollenberg, Rob C. Hoeben |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/15/2/283 |
Similar Items
-
Non-Human Primate-Derived Adenoviruses for Future Use as Oncolytic Agents?
by: Selas T.F. Bots, et al.
Published: (2020-07-01) -
Adenovirus Receptor Expression in Cancer and Its Multifaceted Role in Oncolytic Adenovirus Therapy
by: Lobke C.M. Hensen, et al.
Published: (2020-09-01) -
Oncolytic HSV: Underpinnings of Tumor Susceptibility
by: Chase Kangas, et al.
Published: (2021-07-01) -
Combination of <i>dl922-947</i> Oncolytic Adenovirus and G-Quadruplex Binders Uncovers Improved Antitumor Activity in Breast Cancer
by: Fabiana Napolitano, et al.
Published: (2022-08-01) -
From oncolytic peptides to oncolytic polymers: A new paradigm for oncotherapy
by: Hanmeng Liu, et al.
Published: (2024-01-01)